Editorial Commentary
Optimizing quadruplet therapy for older patients with newly diagnosed multiple myeloma: lessons from the REST trial
Annals of Blood
2026;
11:
10
.
(30 March 2026)
Editorial Commentary
Low dose radiation in indolent lymphoma: from dose optimization to biological insight
Annals of Blood
2026;
11:
9
.
(30 March 2026)
Editorial Commentary
Improved therapy for paroxysmal nocturnal hemoglobinuria
Annals of Blood
2026;
11:
8
.
(30 March 2026)
Editorial Commentary
Driving CAR-T therapy down the GPRC5D fast lane
Annals of Blood
2026;
11:
7
.
(30 March 2026)
Editorial Commentary
Ferritin-guided iron supplementation as a paradigm shift in blood donor care: advancing donor iron management through evidence-based supplementation
Annals of Blood
2026;
11:
6
.
(30 March 2026)
Case Report
Concurrent immune thrombocytopenia and amyotrophic lateral sclerosis with transient improvement in both conditions following efgartigimod: a case report
Annals of Blood
2026;
11:
5
.
(30 March 2026)
Case Report
Multiple crossmatch-incompatible red blood cell transfusions in a patient with anti-Yta (Cartwright) antibodies without hemolytic transfusion reactions: case report
Annals of Blood
2026;
11:
4
.
(30 March 2026)
Review Article
Plasma-derived medicinal products: a narrative review of the multi-layered approach to ensuring pathogen safety
Annals of Blood
2026;
11:
2
.
(30 March 2026)
Review Article
New developments and future trends of artificial blood
Annals of Blood
2026;
11:
1
.
(30 March 2026)
